KRAS and cancer: The main objective of the I-C19 compound is to inhibit K-Ras4B activation, which occurs as shown in Figure 6A. The phosphorylation statuses of proteins involved in the downstream signaling pathway and other essential pathways in cancer, such as angiogenesis, survival and anti-apoptosis, proliferation, metabolism, chemoresistance and DNA repair, are important [7].